Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02926768
Title Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Checkpoint Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NZL | AUS

Facility Status City State Zip Country Details
Research Site Sarasota Florida 34232 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Hackensack New Jersey 07601 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Greenslopes Queensland 4120 Australia Details
Research Site Grafton Auckland 1010 New Zealand Details
Research Site Christchurch 8011 New Zealand Details
Research Site Wellington 6021 New Zealand Details
Research Site Bydgoszcz Kujawsko-Pomorskie 85-231 Poland Details
Research Site Bydgoszcz Kujawsko-Pomorskie 85-796 Poland Details
Research Site Lublin Lubelskie 20-064 Poland Details
Research Site Białystok Podlaskie 15-044 Poland Details
Research Site Poznań Wielkopolskie 60-693 Poland Details
Research Site Szczecin Zachodniopomorskie 70-784 Poland Details
Research Site, Pathumwan Bangkok 10330 Thailand Details
Research Site, Ratchathewi District Bangkok 10400 Thailand Details
Research Site, Bangkok Noi District Bangkok 10700 Thailand Details
Research Site, Muang District Chiang Mai 50200 Thailand Details
Research Site Khon Kaen 40002 Thailand Details
Research Site, Muang Phitsanulok 65000 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field